Alois Alzheimer revisited: Differences in origin of the disease carrying his name

Journal of Neural Transmission

Volumn 113, Issue 11, 2006, Pages 1645-1658

  Maurer, K ^a   Hoyer, S ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain; Energy metabolism; History; Membranes; Nutrition; Sporadic Alzheimer disease

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CHOLESTEROL; INSULIN; INSULIN RECEPTOR; TAU PROTEIN; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

AGING; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CAUSAL ATTRIBUTION; CELL METABOLISM; ENERGY METABOLISM; GENETIC DISORDER; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; MEMBRANE STRUCTURE; METABOLIC DISORDER; ONSET AGE; PHYSICIAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR;

AGE OF ONSET; AGING; ALZHEIMER DISEASE; BRAIN; HUMANS;

EID: 33750486501     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0592-5     Document Type: Review

References (179)

1. J Abad-Rodriguez MJ Ledesma K Craessaerts S Perga M Medina A Delacourte C Dingwall B de Strooper CG Dossi 2004 Neuronal membrane cholesterol loss enhances amyloid peptide generation J Cell Biol 167 953 960
2. MA Abbott DG Wells JR Fallon 1999 The insulin receptor tyrosine kinase substrate p 58/53 and the insulin receptor are components of CNS synapses J Neurosci 19 7300 7308
3. M Adamo MK Raizada D Le Roith 1989 Insulin and insulin-like growth factor receptors in the nervous system Mol Neurobiol 3 71 100
4. E Airnaiz V Jelic O Almkvist LO Wahlund B Winblad S Valind A Nordberg 2001 Impaired cerebral glucose and cognitive functioning predict deterioration in mild cognitive impairment NeuroReport 12 851 855
5. DR Alessi P Cohen 1998 Mechanism of activation and function of protein kinase B Curr Opin Genet Dev 8 55 62
6. A Alzheimer 1907 Über eine eigenartige Erkrankung der Hirnrinde Allg Ztschr Psychiat 64 148 149
7. A Alzheimer 1911 Über eigenartige Krankheitsfälle des späteren Alters Ztschr Ges Neurol Psychiat 4 356 385
8. J Avruch 1998 Insulin signal transduction through protein kinase cascades Mol Cell Biochem 182 31 48
9. P Bak C Tang K Wiesenfeld 1988 Self-organized criticality Phys Rev A 38 365 374
10. WA Banks 2004 The source of cerebral insulin Eur J Pharmacol 490 5 12
11. JK Belanoff K Gross A Yager AF Schatzberg 2001 Corticosteroids and cognition J Psychiatric Res 35 127 145
12. M Bigl M Beck AD Bleyl V Bigl K Eschrich 2000 Altered phosphofructokinase mRNA levels but unchanged isoenzyme pattern in brains from patients with Alzheimer's disease Mol Brain Res 76 411 414
13. M Bigl AD Bleyl D Zedlick T Arendt V Bigl K Eschrich 1996 Changes of activity and isoenzyme pattern of phosphofructokinase in the brains of patients with Alzheimer's disease J Neurochem 67 1164 1171
14. M Bigl MK Brückner T Arendt V Bigl K Eschrich 1999 Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease J Neural Transm 100 499 511
15. I Björkhem D Lütjohann U Diczfalusy L Stahle G Ahlborg J Wahren 1998 Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation J Lipid Res 39 1594 1600
16. JP Blass GE Gibson S Hoyer 2002 The role of the metabolic lesion in Alzheimer's disease J Alzheimers Dis 4 225 232
17. KJ Blusztajn I Lopez Gonzales-Coviella M Logue JH Growdon RJ Wurtman 1990 Levels of phospholipids catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients Brain Res 536 240 244
18. I Braakman J Helenius A Helenius 1992 Role of ATP and disulfide bonds during protein folding in the endoplasmic reticulum Nature 356 260 262
19. 31 P-NRM profiles of Alzheimer disease and multiple subcortical infarct dementia Neurology 39 1423 1427
20. P Bubber V Haroutunian G Fisch JP Blass GE Gibson 2005 Mitochondrial abnormalities in Alzheimer brain: mechanistic implications Ann Neurol 57 695 703
21. G Bucht R Adolfsson F Lithner B Winblad 1983 Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type Acta Med Scand 213 387 392
22. MG Buse KA Robinson BA Marshall RC Hresko MM Mueckler 2002 Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles Am J Physiol Endocrinol Metab 283 E241 E250
23. FI Comer GW Hart 2001 Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II Biochemistry 40 7845 7852
24. A Convit OT Wolf C Tarshish MJ DeLeon 2003 Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly Proc Natl Acad Sci USA 100 2019 2022
25. S Craft S Asthana G Schellenberg M Cherrier LD Baker J Newcomer S Plymate S Latendresse A Petrova J Raskind E Peskind C Lofgren K Grimwood 1999 Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender Neuroendocrinology 70 146 152
26. S Craft E Peskind MW Schwartz GD Schellenberg M Raskind D Porte Jr 1998 Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype Neurology 50 164 168
27. DA Cross PW Watt M Shaw J von der Kaay CP Downes JC Holder P Cohen 1997 Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-sensitive pathways in skeletal muscle and adipose tissue FEBS Lett 406 211 215
28. DAE Cross DR Alessi P Cohen M Andjelkovich BA Hemmings 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated protein kinase Nature 378 785 789
29. RG Cutler J Kelly K Storie WA Pedersen A Tammara K Hatanpaa JC Troncorso PT Mattson 2004 Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease Proc Natl Acad Sci USA 101 2070 2075
30. MR D'Andrea RG Nagele HY Wang PA Peterson DHS Lee 2001 Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease Histopathology 38 120 134
31. DK Dastur 1985 Cerebral blood flow and metabolism in normal aging, pathological aging, and senile dementia J Cereb Blood Flow Metab 9 2 19
32. KL Davis BM Davis BS Greenwald RC Mohs AA Mathé CA Johns TB Horvath 1986 Cortisol and Alzheimer's disease. I: Basal studies Am J Psychiatry 143 300 305
33. VMS de Bruin MCM Vieira MNM Rocha GSP Viana 2002 Cortisol and dehydroepiandrosterstone sulphate plasma levels and their relationship to aging, cognitive function, and dementia Brain Cogn 50 316 323
34. N Demaurex W Furuya S D'Souza JS Bonifacino S Grinstein 1998 Mechanism of acidification of the trans-Golgi network (TGN). In situ measurements of pH using retrieval of TGN 38 and furin from the cell surface J Biol Chem 273 2044 2051
35. DJ de Quervain R Poirsier MA Wollmer LM Grimaldi M Tsolaki JR Streffer C Hock RM Nitsch MH Mohajeri A Papassotiropoulos 2004 Glucocorticoid-related genetic susceptibility for Alzheimer's disease Hum Mol Genet 13 47 52
36. JU Devaskar SJ Giddings PA Rajakumar LR Carnaghi RK Menon DS Zahn 1994 Insulin gene expression and insulin synthesis in mammalian neuronal cells J Biol Chem 269 8445 8454
37. JM Dietschy SD Turley 2004 Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal J Lipid Res 45 1375 1397
38. R Distl V Meske TG Ohm 2001 Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons Acta Neuropathol 101 547 554
39. AJ Dorner LC Wasley RJ Kaufman 1990 Protein dissociation from GRP 78 and secretion are blocked by depletion of cellular ATP levels Proc Natl Acad Sci USA 87 7429 7432
40. DA Drachman D Noffsinger BJ Sahakian S Kurdziel P Fleming 1980 Aging, memory and the cholinergic system: a study of dichotic listening Neurobiol Aging 1 39 43
41. R Duara C Grady J Haxby S Sundaram NR Cutler L Heston A Moore N Schlageter R Larson SI Rapoport 1986 Positron emission tomography in Alzheimer's disease Neurology 36 879 887
42. GP Eckert NJ Cairns A Maras WF Gattaz WE Müller 2000 Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease Dement Geriatr Cogn Disord 11 181 186
43. M Erecinska IA Silver 1989 ATP and brain function J Cereb Blood Flow Metab 9 2 19
44. DA Evans H Funkenstein MS Albert PA Scherr NR Cook MJ Chown LE Hebert CH Hennekens JO Taylor 1989 Prevalence of Alzheimer's disease in a common population of older persons: higher than previously reported J Am Med Assoc 262 2551 2556
45. W Farris S Mansourian Y Chang L Lindsay EA Eckman MP Frosch CB Eckman RE Tanzi DE Selkoe S Guenette 2003 Insulin-degrading enzyme regulates the levels of insulin, amyloid-β protein and the β-amyloid precursor protein intracellular domain in vivo Proc Natl Acad Sci USA 100 4162 4167
46. NL Foster TN Chase K Mansi R Brooks P Fedio NJ Patronas G DiChiro 1984 Cortical abnormalities in Alzheimer's disease Ann Neurol 16 649 654
47. L Frölich 2002 The cholinergic pathology in Alzheimer's disease - discrepancies between clinical experience and pathophysiological findings J Neural Transm 109 1003 1014
48. L Frölich D Blum-Degen HG Bernstein S Engelsberger J Humrich S Laufer D Muschner A Thalheimer A Türk S Hoyer 1998 Insulin and insulin receptors in the brain in aging and sporadic Alzheimer's disease J Neural Transm 105 423 438
49. H Fukuyama M Ogawa H Yamauchi S Yamaguchi J Kimura Y Yonekura J Konishi 1994 Altered cerebral energy metabolism in Alzheimer's disease: a PET study J Nucl Med 35 1 6
50. L Gasparini GK Gouras R Wang RS Gross MF Beal P Greengard H Xu 2001 Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneural β-amyloid and requires mitogen-activated protein kinase signalling J Neurosci 21 2561 2570
51. WF Gattaz A Maras NJ Cairns R Levy H Förstl 1995 Decreased phospholipase A2 activity in Alzheimer brains Biol Psychiatry 37 13 17
52. SB Gaudreault D Dea J Poirier 2004 Increased caveolin-1 expression in Alzheimer's disease brain Neurobiol Aging 25 753 759
53. MJ Gething J Sambrook 1992 Protein folding in the cell Nature 355 33 45
54. EL Gibbs WG Lennox LF Nims FA Gibbs 1942 Arterial and cerebral venous blood: arterial venous differences in man J Biol Chem 114 325 332
55. GE Gibson R Jope JP Blass 1975 Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces Biochem J 148 17 23
56. F Giorgino A Almahfouz LJ Goodyear RJ Smith 1993 Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo J Clin Invest 91 2020 2030
57. BJ Goldstein 1993 Regulation of insulin receptor signalling by protein-tyrosine dephosphorylation Receptor 3 1 15
58. CX Gong F Liu I Grundke-Iqbal K Iqbal 2006 Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-Glc NAcylation J Alzheimers Dis 9 1 12
59. U Gottstein A Bernsmeier I Sedlmeyer 1963 Der Kohlenhydratstoffwechsel des menschlichen Gehirns. I. Untersuchungen mit substratspezifischen enzymatischen Methoden bei normaler Hirndurchblutung Klin Wschr 41 943 948
60. GK Gouras J Tsai J Naslund B Vincent M Edgard JP Greenfield V Haroutunian JS Buxbaum H Xu P Greengard NR Relkin 2000 Intraneuronal βA-41 accumulation in human brain Am J Pathol 156 15 20
61. J Hardy DJ Selkoe 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road of therapeutics Science 297 353 356
62. HU Häring D Kirsch B Obermeier B Ermel F Machicao 1986 Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro Biochem J 234 59 66
63. GW Hart 1997 Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins Annu Rev Biochem 66 315 335
64. KA Heidenreich NR Zahniser P Berhanu D Brandenburg JM Olefsky 1983 Structural differences between insulin receptors in the brain and peripheral target tissues J Biol Chem 258 8527 8530
65. GA Held DH Solina DT Keane WJ Haag PM Horn G Grinstein 1990 Experimental study of critical-mass fluctuations in an evolving sandpile Physic Rev Lett 69 1120 1123
66. N Henneberg S Hoyer 1994 Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat Neurosci Lett 175 153 156
67. K Herholz E Salmon D Perani DJ Baron V Holthoff L Frölich P Schönknecht K Ito R Mielke E Kalbe 2002 Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDGPET NeuroImage 17 302 316
68. B Hess 1983 Non-equilibrium dynamics of biochemical processes Hoppe-Seylers Z Physiol Chem 364 1 20
69. B Hess 1990 Order and chaos in chemistry and biology Fresenius J Anal Chem 337 459 468
70. F Hirata J Axelrod 1980 Phospholipid methylation and biological signal transmission Science 209 1082 1090
71. MH Hollness ML Langdown MC Sugden 2000 Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of type 2 diabetes mellitus Biochem J 349 657 665
72. MF Hong VMY Lee 1997 Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons J Biol Chem 272 19547 19553
73. WJG Hoogendijk MGP Feenstra MHA Botterblom J Gilhuis IEC Sommer W Kamphorst P Eikelenboom DF Swaab 1999 Increased activity of surviving locus ceruleus neurons in Alzheimer's disease Ann Neurol 45 82 91
74. S Hoyer 1970 Der Aminosäurenstoffwechsel des normalen menschlichen Gehirns Klin Wschr 48 1239 1243
75. S Hoyer 1986 Senile dementia and Alzheimer's disease: Brain blood flow and metabolism Prog Neuropsychopharmacol Biol Psychiatry 10 447 478
76. S Hoyer 1992 Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases Mol Chem Neuropathol 16 207 224
77. S Hoyer 1998 Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis: J Neural Transm 105 415 422
78. S Hoyer K Plaschke 2004 The aging brain. The burden of life (?) T Herdegen J Delgado Garcia Brain damage and repair. From molecular research to clinical therapy Kluwer Dordrecht 1 22
79. S Hoyer R Nitsch K Oesterreich 1991 Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer-type: a cross-sectional comparison against advanced late-onset dementia and incipient early-onset cases J Neural Transm (PD-Sect) 3 1 14
80. S Hoyer L Prem S Sorbi L Amaducci 1993 Stimulation of glycolytic key enzymes in cerebral cortex by insulin NeuroReport 4 991 993
81. U Igbavboa NA Avdulov F Schröder WG Wood 1996 Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice J Neurochem 66 1717 1725
82. K Ishiguro A Shiratsuchi S Sato A Omori M Arioka S Kobayashi T Uchida 1993 Glycogen synthase kinase 3-beta is identical to tau protein kinase I generating several epitopes of paired helical filaments FEBS Lett 325 167 172
83. J Joseph B Shukitt-Hale NA Denisova A Martin G Perry MA Smith 2001 Copernicus revisited: amyloid beta in Alzheimer's disease Neurobiol Aging 22 131 146
84. N Kadekaro AM Crane L Sokoloff 1985 Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat Proc Natl Acad Sci USA 82 6010 6013
85. A Kakio S Nishimoto K Yanagisawa Y Kozutsumi K Matsuzaki 2001 Cholesterol-dependent formation of GM1 ganglioside-bound amyloid-β-protein, an endogenous seed for Alzheimer amyloid J Biol Chem 276 24985 24990
86. RJ Kaufman 1999 Stress signalling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls Genes Dev 13 1211 1233
87. RA Kauppinen DG Nichols 1986 Failure to maintain glycolysis in anoxic nerve terminal J Neurochem 47 1864 1869
88. JN Keller Z Pang JW Geddes JG Begley A Germeyer G Waeg MP Mattson 1997 Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal J Neurochem 69 273 284
89. C Kirsch GP Eckert AR Koudinov WE Müller 2003 Brain cholesterol, statins and Alzheimer's disease Pharmacopsychiatry 36 Suppl 2 S113 S119
90. C Kirsch GP Eckert WE Mueller 2002 Cholesterol attenuates the membrane perturbing properties of β-amyloid peptides Amyloid 9 149 159
91. J Klein 2000 Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids J Neural Transm 107 1027 1063
92. M Kliegel C Rott V d'Heureuse G Becker P Schönemann 2001 Dementia in the very old is not a necessity: results from the Heidelberg Centenarian Study Z Gerontopsychol-psychiatrie 14 169 180
93. IV Kurochkin S Goto 1994 Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme FEBS Lett 345 33 37
94. JM Kyriakis RE Hausman SW Peterson 1987 Insulin stimulates choline acetyltransferase activity in cultured embryonic chicken retina neurons Proc Natl Acad Sci USA 84 7463 7467
95. MD Ledesma J Abad-Rodriguez C Galvan E Biondi P Navarro A Delacourte C Dingwall CG Dotti 2003 Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains EMBO Rep 4 1190 1196
96. MD Ledesma JS Da Silva A Schevchenko M Wilm CG Dotti 2003 Proteonic characterization of neuronal sphingolipid-cholesterol microdomains: role in plasminogen activation Brain Res 987 107 116
97. M Lesort RS Jope GVW Johnson 1999 Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3β and Fyen tyrosine kinase J Neurochem 72 576 584
98. L Liscum NJ Munn 1999 Intracellular cholesterol transport Biochim Biophys Acta 1438 19 37
99. D Lütjohann O Breuer G Ahlborg I Nennesmo A Siden U Diczfalusy Björkhem 1996 Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24 S-hydroxysterol from the brain into the circulation Proc Natl Acad Sci USA 93 9799 9804
100. RW Mahley SC Rall Jr 2000 Apolipoprotein E: far more than a lipid transport protein Annu Rev Genom Hum Genet 1 507 537
101. EM Mandelkow G Drewes J Biernet N Gustke J van Lint JR Vandeenheede E Mandelkow 1992 Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau FEBS Lett 314 215 221
102. RP Mason WJ Shoemaker L Shajenko TE Chambers LG Herbette 1992 Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol Neurobiol Aging 13 413 419
103. F Mastrogiacomo C Bergeron SJ Kish 1993 Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease J Neurochem 61 2007 2014
104. DH Mauch J Nägler S Schumacher EC Göritz A Otto FW Pfrieger 2001 CNS synaptogenesis promoted by glia-derived cholesterol Science 294 1354 1357
105. JR [tmp] McDermott AM Gibson 1997 Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme Neurochem Res 22 49 56
106. J [tmp] McLaurin A Chakrabartty 1996 Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides J Biol Chem 271 26482 26489
107. J [tmp] McLaurin T Franklin PE Fraser A Chakrabartty 1998 Structural transitions associated with the interaction of Alzheimer β-amyloid peptides with gangliosides J Biol Chem 273 4506 4515
108. M Michikawa K Yanagisawa 1999 Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death J Neurochem 72 2278 2285
109. R Mielke K Herholz M Grond WD Heiss 1994 Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas Dementia 5 36 41
110. S Minoshima B Giordani S Berent KA Frey DE Kuhl 1997 Metabolic reduction in the posterior cingulated cortex in very early Alzheimer's disease Ann Neurol 42 85 94
111. RE Mirollo SH Strogatz 1990 Synchronization of pulse-coupled biological oscillators SIAM J Appl Math 50 1645 1649
112. M Molander-Melin K Blennow N Bogdanovic B Dellheden JE Mansson P Fredman 2005 Structural membrane alterations in Alzheimer brains found to be associated with regional disease development, increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains J Neurochem 92 171 182
113. RM Nitsch JK Busztajin AG Pittas BE Slack JH Growdon RJ Wurtman 1992b Evidence for a membrane defect in Alzheimer's disease brain Proc Natl Acad Sci USA 89 1671 1675
114. RM Nitsch BE Slack RJ Wurtman J Growdon 1992a Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors Science 258 304 307
115. A Ott MMB Breteler F van Harskamp JJ Clauss THM van der Cammen DE Grobbee A Hofman 1995 Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study Br J Med 310 970 973
116. WD Parker J Parks CM Filly BK Kleinschmidt-DeMasters 1994 Electron transport chain defects in Alzheimer's disease brain Neurology 44 1090 1096
117. ET Parkin AJ Turner NM Hooper 1999 Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein Biochem J 344 23 30
118. W Paschen A Frandsen 2001 Endoplasmic reticulum dysfunction - a common denominator for cell injury in acute and degenerative diseases of the brain? J Neurochem 79 719 725
119. M Pascualy EC Petrie K Brodkin ER Peskind W Wilkinson MA Raskind 2000 Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressure test in Alzheimer's disease Biol Psychiatry 48 247 254
120. A Perez L Morelli JC Cresto EM Castano 2000 Degradation of soluble amyloid β-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brain Neurochem Res 25 247 255
121. EK Perry RG Perry BE Tomlinson G Blessed PH Gibson 1980 Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic "compartment" of pyruvate dehydrogenase Neurosci Lett 18 105 110
122. ER Peskind R Elrod DJ Dobie M Pascualy E Petrie R Jensen K Brodkin S Murray RC Veith MA Raskind 1998 Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging Neuropsychopharmacology 19 465 471
123. ER Peskind CW Wilkinson EC Schellenberg MA Raskind 2001 Increased CSF cortisol in AD is a function of APOE genotype Neurology 56 1094 1098
124. ER Peskind D Wingerson S Murray M Pascualy DJ Dobie P LeCorre R LeVerge RC Veith MA Raskind 1995 Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine Arch Gen Psychiatry 52 774 782
125. SS Petanceska S Gandy 1999 The phophatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein J Neurochem 73 2316 2320
126. JW Pettegrew WE Klunk E Kanal K Panchalingam RJ [tmp] McClure 1995 Changes in brain membrane phospholipids and high-energy phosphate metabolism precede dementia Neurobiol Aging 16 973 975
127. 31P nuclear magnetic resonance study of the brain in Alzheimer's disease J Neuropathol Exp Neurol 47 235 248
128. CJ Phiel CA Wilson VMY Lee PS Klein 2003 GSK-3α regulates production of Alzheimer's disease amyloid-β peptides Nature 423 435 439
129. CR Plata-Salaman 1991 Insulin in the cebebrospinal fluid Neurosci Biobehav Rev 15 243 258
130. I Prigogine 1989 What is entropy? Naturwissenschaften 76 1 8
131. AW Procter AM Palmer PT Francis SL Lowe D Neary E Murphy R Doshi DM Bowen 1988 Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease J Neurochem 50 790 802
132. S Ramakrishna WB Benjamin 1998 Insulin action rapidly decreases multifunctional protein kinase activity in rat adipose tissue J Biol Chem 263 12677 12681
133. MT Rinaudo M Curto R Bruno C Marino V Rossetti M Mostert 1987 Evidence of an insulin generated pyruvate dehydrogenase stimulating factor in rat brain plasma membranes Ital J Biochem 19 909 913
134. EJ Rivera A Golding N Fulmer R Tavares JR Wands SM de la Monte 2005 Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine J Alzheimers Dis 8 247 268
135. HM Röder VM Ingram 1991 Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios J Neurosci 11 3325 3342
136. AE Roher N Weiss TA Kokjohn YM Kuo W Kalback J Anthony D Watson DC Luehrs L Sue D Walker M Emmerling W Goux T Beach 2002 Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease Biochemistry 41 11080 11090
137. BM Ross A Moszczynska J Erlich SJ Kish 1998 Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acetyltransferase activity and decreased phospholipase A2 activity J Neurochem 70 786 793
138. S Rossner U Weberham J Yu L Kirazor R Schliebs JR Perez-Polo V Bigl 1997 In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity Eur J Neurosci 9 2125 2134
139. JE Rothman 1996 The protein machinery of vesicle budding and fusion Protein Sci 5 185 194
140. JE Rothman L Orci 1992 Molecular dissection of the secretory pathway Nature 355 409 415
141. JE Rothman FT Wielandt 1996 Protein sorting by transport vesicles Science 272 227 234
142. R Rupprecht F Holsboer 1999 Neuroactive steroids: mechanism of action and neuropsychopharmacological perspectives Trends Neurosci 22 410 416
143. W Sacks 1957 Cerebral metabolism of isotopic glucose in normal brain subjects J Appl Physiol 10 37 44
144. M Salkovic-Petrisic Z Lackovic 2005 Insulin resistant brain state and its link to diabetes mellitus Period Biol 107 137 146
145. M Salkovic-Petrisic F Tribl M Schmidt S Hoyer P Riederer 2006 Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway J Neurochem 96 1005 1015
146. A Sato Y Sato 1995 Cholinergic neural regulation of regional cerebral blood flow Alzheimer Dis Ass Disord 9 28 38
147. R Schechter J Whitmire L Holtzclaw M George JU Devaskar 1992 Developmental regulation of insulin in the mammalian central nervous system Brain Res 582 27 37
148. F Schroeder AA Frolov EJ Murphey BP Atshaves RJ Jefferson LX Pu WG Wood WB Foxworth AB Kier 1996 Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking Proc Soc Exp Biol Med 213 150 177
149. JR Seckl BR Walker 2001 Minireview: 11 beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action Endocrinology 142 1371 1376
150. O Seksek J Biwersi AS Verkman 1995 Direct measurement of trans-Golgi pH on living cells and regulation by second messengers J Biol Chem 270 4967 4970
151. Siesjö BK (1978) Brain energy metabolism. Wiley, Chichester, pp 56-100, 281-284
152. K Simons D Toomre 2000 Lipid rafts and signal transduction Nat Rev Mol Cell Biol 1 31 39
153. NR Sims DM Bowen SJ Allen CCT Smith D Neary DJ Thomas AN Davison 1983a Presynaptic cholinergic dysfunction in patients with dementia J Neurochem 40 503 509
154. 14C) glucose in vivo in human neocortex J Neurochem 41 1329 1334
155. H Singh S Usher A Poulos 1989 Mitochondrial and peroxisomal beta-oxidation of stearic and lignoceric acids by rat brain J Neurochem 53 1711 1718
156. M Söderberg C Edlund I Alafuzoff K Kristensson G Dallner 1992 Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer type J Neurochem 59 1646 1653
157. M Söderberg C Edlund K Kristensson G Dallner 1991 Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease Lipids 26 412 425
158. L Sokoloff 1981 Localization and functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose J Cereb Blood Flow Metab 1 7 36
159. DC Solano M Sironi C Bonfini SB Solarte S Govoni M Racchi 2000 Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway FASEB J 14 1015 1022
160. S Sorbi ED Bird JP Blass 1983 Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain Ann Neurol 13 72 78
161. AA Spector MA Yorek 1985 Membrane lipid composition and cellular function J Lipid Res 26 1015 1035
162. E Steen BM Terry EJ Rivera JL Cannon TR Neely R Tavares XJ Xu JR Wands SM de la Monte 2005 Impaired insulin and insulin-like growth factor expression and signalling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis 7 63 80
163. FF Sun WE Fleming BM Taylor 1993 Degradation of membrane phospholipids in the cultured human astroglial cell line UC-11 MG during ATP depletion Biochem Pharmacol 45 1149 1155
164. L Svennerholm CG Gottfries 1994 Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset from (type I) and demyelination in late-onset (type II) J Neurochem 62 1039 1047
165. DF Swaab FC Raadsheer EF Endert MA Hofman WC Kamphorst R Ravid 1994 Increases in cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid Neuroendocrinology 6 681 687
166. + - ATPase by insulin: Why and how? Mol Cell Biochem 182 121 133
167. RE Tanzi L Bertram 2001 New frontiers in Alzheimer's disease genetics Neuron 32 181 184
168. J Unger TH [tmp] McNeill RT Moxley M White A Moss JN Livingston 1989 Distribution of insulin receptor-like immunoreactivity in the rat forebrain Neuroscience 31 143 157
169. JE Vance H Hayashi B Karten 2005 Cholesterol homeostasis in neurons and glial cells Semin Cell Dev Biol 16 193 212
170. A Vanhaesebroeck DR Alessi 2000 The PIK3K-PDK1 connection: more than just a road to PKB Biochem J 346 561 576
171. K Vekrellis Z Ye WQ Qiu D Walsh D Hartle U Chesneau MR Rosner DJ Selkoe 2000 Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme J Neurosci 20 1657 1665
172. C Verde MC Pascale G Martive LV Lotti MR Torrisi A Helenius S Bonatti 1995 Effect of ATP depletion and DTT on the transport of membrane proteins from the endoplasmic reticulum and intermediate compartment to the Golgi complex Eur J Cell Biol 67 267 274
173. KL Wong GM Tyce 1983 Glucose and amino acid metabolism in rat brain during sustained hypoglycaemia Neurochem Res 8 401 415
174. Y Wu FF Sun DM Tong 1996 Changes in membrane properties during energy depletion-induced cell injury studied with fluorescence microscopy Biophys J 71 91 100
175. K Yanagisawa Y Ihara 1998 GM1 ganglioside-bound amyloid β-protein in Alzheimer's disease brain Neurobiol Aging 19 S65 S67
176. K Yanagisawa A Odaka N Suzuki Y Ihara 1995 GM1 ganglioside- bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease Nat Med 1 1062 1066
177. K Yasojima EG [tmp] McGeer PL [tmp] McGeer 2001 3-hydroxy-3- methylglutaryl-coenzyme. A reductase mRNA in Alzheimer and control brain Neuro Report 12 2935 2938
178. H Yki-Jarvinen A Virkamaki MC Daniels D [tmp] McClain WK Gottschalk 1998 Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle protein in vivo Metabolism 47 449 455
179. H Zhang NH Sternberger LJ Rubinstein MM Herman LI Binder LA Sternberger 1989 Abnormal processing of multiple proteins in Alzheimer's disease Proc Natl Acad Sci USA 86 8045 8049